Adequate Reserves. GMN shall maintain at all times during the Term an inventory of Raw Materials sufficient in GMN’s reasonable judgment to maintain continuity of supply of Product to PDL, based on the accepted purchase orders, provided that GMN shall use up the PDL-Provided Materials listed in Annex G. All PDL-Provided Materials provided to GMN from PDL to perform GMN’s obligations under the Agreement shall be licensed or otherwise provided to GMN cost-free.
Appears in 3 contracts
Sources: Clinical Drug Substance Supply Agreement (Facet Biotech Corp), Asset Purchase Agreement (PDL Biopharma, Inc.), Clinical Drug Substance Supply Agreement (Facet Biotech Corp)